Other

Change in AR

Gilead Sciences Change in AR decreased by 140.2% to -$134.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 69.6%, from -$79.00M to -$134.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 7, 2026

How to read this metric

A significant increase may signal aggressive revenue recognition or collection issues, while a decrease suggests improved cash conversion cycles.

Detailed definition

The net change in the balance of accounts receivable during the reporting period, representing the difference between cr...

Peer comparison

Should track closely with revenue growth; significant deviations from revenue trends warrant investigation.

Metric ID: anet_change_in_accounts_receivable

Historical Data

16 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$41.00M-$699.00M$452.00M$372.00M$281.00M-$635.00M$612.00M-$220.00M$66.00M$29.00M-$162.00M-$72.00M-$79.00M$292.00M$333.00M-$134.00M
QoQ Change<-999%+164.7%-17.7%-24.5%-326.0%+196.4%-135.9%+130.0%-56.1%-658.6%+55.6%-9.7%+469.6%+14.0%-140.2%
YoY Change+785.4%+9.2%+64.5%-178.3%+110.4%-126.5%+67.3%-219.7%+906.9%+305.6%-69.6%
Range-$699.00M$612.00M
CAGR+37.1%
Avg YoY Growth+150.5%
Median YoY Growth+64.5%

Frequently Asked Questions

What is Gilead Sciences's change in ar?
Gilead Sciences (GILD) reported change in ar of -$134.00M in Q1 2026.
How has Gilead Sciences's change in ar changed year-over-year?
Gilead Sciences's change in ar decreased by 69.6% year-over-year, from -$79.00M to -$134.00M.
What does change in ar mean?
The net increase or decrease in money owed to the company by customers.